Global Embolization Microsphere Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Embolization Microsphere Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream.
Embolization Microsphere report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Embolization Microsphere market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Uterine Fibroid Embolization and Prostatic Artery Embolization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Embolization Microsphere industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Embolization Microsphere key manufacturers include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific, Terumo Corporation, HENGRUI Medical and INterface BIOmaterials B.V., etc. Sirtex Medical, Merit Medical, Cook Medical are top 3 players and held % sales share in total in 2022.
Embolization Microsphere can be divided into 2ml Syringe, 3ml Syringe, 8ml Syringe and Other, etc. 2ml Syringe is the mainstream product in the market, accounting for % sales share globally in 2022.
Embolization Microsphere is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the Embolization Microsphere industry development. In 2022, global % sales of Embolization Microsphere went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Embolization Microsphere market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Segment by Type
2ml Syringe
3ml Syringe
8ml Syringe
Other
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Embolization Microsphere market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Embolization Microsphere, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Embolization Microsphere industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Embolization Microsphere in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Embolization Microsphere introduction, etc. Embolization Microsphere Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Embolization Microsphere market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Embolization Microsphere report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Embolization Microsphere market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Uterine Fibroid Embolization and Prostatic Artery Embolization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Embolization Microsphere industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Embolization Microsphere key manufacturers include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific, Terumo Corporation, HENGRUI Medical and INterface BIOmaterials B.V., etc. Sirtex Medical, Merit Medical, Cook Medical are top 3 players and held % sales share in total in 2022.
Embolization Microsphere can be divided into 2ml Syringe, 3ml Syringe, 8ml Syringe and Other, etc. 2ml Syringe is the mainstream product in the market, accounting for % sales share globally in 2022.
Embolization Microsphere is widely used in various fields, such as Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, etc. Uterine Fibroid Embolization provides greatest supports to the Embolization Microsphere industry development. In 2022, global % sales of Embolization Microsphere went into Uterine Fibroid Embolization filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Embolization Microsphere market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Segment by Type
2ml Syringe
3ml Syringe
8ml Syringe
Other
Segment by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Embolization Microsphere market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Embolization Microsphere, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Embolization Microsphere industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Embolization Microsphere in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Embolization Microsphere introduction, etc. Embolization Microsphere Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Embolization Microsphere market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices